Martie Zakas
Analyst · D.A. Davidson. Your line is open
Thanks, Scott, and good morning, everyone. I hope you continue to be healthy and safe. I'll begin with our third quarter consolidated GAAP and non-GAAP financial results then review our segment performance and finish with a discussion of our cash flow and liquidity. During the third quarter, we generated consolidated net sales of $228.5 million, which decreased 16.7% or $45.8 million as compared with third quarter last year. The decrease was primarily due to reduced shipment volumes related to the pandemic seen across most of our product lines and was partially offset by higher pricing. Our gross profit this quarter decreased 22.1% or $21.5 million to $75.7 million with a gross margin of 33.1%. Gross margin decreased 230 basis points versus the prior year, primarily due to the decrease in shipment volumes and $5.2 million of expenses related to the pandemic, including certain unfavorable volume variances, voluntary emergency paid leave for employees and additional sanitation and cleaning fees. As a reminder, positive sales in the prior year included $2.3 million of costs associated with the Krausz acquisition. Excluding the acquisition costs in the prior year quarter, our gross margin decreased by 320 basis points. Selling, general, and administrative expenses of $47.1 million in the quarter decreased $400,000 versus the prior year. The decrease was primarily due to lower expenses relating to the pandemic, including reduced travel, trade shows, events, temporary furloughs and pay reductions for employees. The benefits from these actions were partially offset by an increase in personnel-related costs, professional fees, and IT-related activities. SG&A as a percent of net sales was 20.6% in the third quarter, compared to 17.3% in the prior year. Operating income of $20 million decreased 57.6% in the third quarter, compared to $47.2 million in the prior year. Operating income included strategic reorganization and other charges of $8.6 million in the quarter, which primarily relate to an accrual for a potential settlement with Siemens, facility relocation expenses and senior executive severance costs. Turning now to our consolidated non-GAAP results. Adjusted operating income of $28.6 million decreased 45% or $23.4 million in the quarter. The decrease is primarily due to lower volumes and higher expenses related to the pandemic at both infrastructure and technologies. Expenses associated with addressing the pandemic reduced our consolidated adjusted operating income by approximately $5.7 million during the third quarter. However, we also benefited from lower SG&A expenses relating to the pandemic resulting in estimated net COVID-19 related expenses of approximately $2.5 million. Adjusted EBITDA of $43.8 million decreased 33% or $21.6 million, leading to an adjusted EBITDA margin of 19.2% and decremental margin of 47%. For the last 12 months, adjusted EBITDA was $189.9 million or 19.7% of net sales. For the quarter, we generated adjusted net income per share of $0.11 compared with $0.24 in the prior year. Turning now to segment performance, starting with Infrastructure. Infrastructure net sales of $209.9 million decreased 16.1% or $40.3 million as compared with the prior year, primarily due to reduced shipment volumes related to the pandemic, partially offset by higher pricing. Adjusted operating income of $43.8 million decreased 30.4% or $19.1 million in the quarter. The decrease is primarily due to lower shipment volumes and $4.5 million of expenses related to the pandemic, partially offset by higher pricing and lower SG&A expenses related to the pandemic. Adjusted EBITDA of $56 million decreased 24.5% or $18.2 million, leading to an adjusted EBITDA margin of 26.7% and a decremental margin of 45% in the quarter. Moving on to Technologies. Technologies net sales of $18.6 million decreased 22.8% or $5.5 million as compared with the prior year, primarily due to lower volumes related to the pandemic, partially offset by higher pricing. Much of our Technologies business is project-related, so shelter-in-place orders negatively impacted our volumes this quarter for metering and leak detection products and services. Adjusted operating loss was $3.8 million as compared with an operating loss of $2.2 million in the prior year. This was primarily due to lower shipment volumes and $700,000 of expenses related to the pandemic, partially offset by lower SG&A expenses and higher pricing. Technologies adjusted EBITDA was a loss of $1.5 million in the quarter as compared with a loss of $200,000 in the prior year, leading to a decremental margin of 24% in the quarter. Moving on to cash flow. Net cash provided by operating activities for the nine months ended June 30, 2020, improved $60 million to $77.8 million, primarily driven by improvements in working capital management and the timing of tax payments. As a reminder, cash provided by operating activities was adversely affected by the $22.2 million payment associated with the Walter tax settlement in the first quarter of this year. Additionally, for the 2020 fourth quarter, our tax payments will be higher than usual due to the changes in filing dates from June to July. We invested $13.9 million in capital expenditures during the third quarter, bringing the year-to-date total to $51.2 million. Free cash flow for the year-to-date period improved $61.7 million to $26.6 million. As a reminder, our debt includes $450 million of 5.5% senior unsecured notes, and we also have an asset-based lending agreement with up to $175 million revolving facility. We did not have any amounts borrowed under our ABL agreement at the quarter-end. At June 30, 2020, we had total debt of $447.6 million and cash and cash equivalents of $170.7 million. At the end of the third quarter, our net debt leverage ratio was 1.5x. We currently have no debt maturities prior to June 2026. Our 5.5% notes have no financial maintenance covenants, and our ABL agreement is not subject to any financial maintenance covenants unless we exceed the minimum availability thresholds. On July 30, 2020, we renewed and extended our ABL agreement, which was set to expire in 2021. The new agreement has similar terms and terminates on July 29, 2025. Based on June 30, 2020 data, we had approximately $116.1 million of excess availability under the ABL agreement, which brings our total liquidity to $286.8 million. With a strong balance sheet and ample liquidity, we believe that we are well positioned to face the future challenges from the COVID-19 pandemic. I'll turn the call back to Scott to talk more about market conditions.